Prospective Study of Induction Medications Used in the Trauma RSI
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Feb 27, 2020
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare three different medications—propofol, etomidate, and ketamine—used to help patients with trauma during a procedure called intubation, which is when a tube is placed in the airway to help with breathing. The study aims to find out which of these medications works best for adult trauma patients who need intubation within 24 hours of being admitted to the hospital.
To participate in the trial, individuals must be at least 18 years old and have experienced trauma that requires intubation soon after being admitted to the emergency department or operating room. However, people who were intubated without these medications or who received different medications will not be eligible. If you join the trial, you can expect to receive one of the three medications as part of your treatment, and the outcomes will be closely monitored to help determine the best option for future patients in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Trauma patients \>=18 yo requiring intubation within 24 hours of admission in either the ED or OR
- • Patients received propofol, etomidate, or ketamine for induction agent
- Exclusion Criteria:
- • Patients who were intubated without induction agent medications
- • Patients intubated outside of the hospital or in the field
- • Patients who were intubated with an induction agent other than etomidate, ketamine, or propofol
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Catherine M Kuza, MD
Principal Investigator
Keck School of Medicine of the University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials